BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37689825)

  • 1. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia.
    Dobish KK; Wittorf KJ; Swenson SA; Bean DC; Gavile CM; Woods NT; Ghosal G; Hyde RK; Buckley SM
    Leukemia; 2023 Nov; 37(11):2197-2208. PubMed ID: 37689825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis.
    Wittorf KJ; Weber KK; Swenson SA; Buckley SM
    Exp Hematol; 2022 Oct; 114():33-42.e3. PubMed ID: 35987460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells.
    Schnetzke U; Fischer M; Kuhn AK; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):605-15. PubMed ID: 23263202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JUNB-FBXO21-ERK axis promotes cartilage degeneration in osteoarthritis by inhibiting autophagy.
    Lin Z; Miao J; Zhang T; He M; Wang Z; Feng X; Bai L
    Aging Cell; 2021 Feb; 20(2):e13306. PubMed ID: 33450132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fbxo21 regulates the epithelial-to-mesenchymal transition through ubiquitination of Nr2f2 in gastric cancer.
    Jiang Y; Liu X; Shen R; Gu X; Qian W
    J Cancer; 2021; 12(5):1421-1430. PubMed ID: 33531987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.
    Sanarico AG; Ronchini C; Croce A; Memmi EM; Cammarata UA; De Antoni A; Lavorgna S; Divona M; Giacò L; Melloni GEM; Brendolan A; Simonetti G; Martinelli G; Mancuso P; Bertolini F; Coco FL; Melino G; Pelicci PG; Bernassola F
    Leukemia; 2018 Apr; 32(4):911-919. PubMed ID: 29209041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo.
    Su Y; Li X; Ma J; Zhao J; Liu S; Wang G; Edwards H; Taub JW; Lin H; Ge Y
    Biochem Pharmacol; 2018 Feb; 148():13-26. PubMed ID: 29208365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
    Doepfner KT; Spertini O; Arcaro A
    Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
    Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
    Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
    Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
    J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
    Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
    Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
    Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in
    Wang H; Shah CA; Hu L; Huang W; Platanias LC; Eklund EA
    J Biol Chem; 2020 Jul; 295(28):9663-9675. PubMed ID: 32467231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling.
    Wang P; Zhang J; Zhang H; Zhang F
    Mol Cell Biochem; 2023 Mar; 478(3):433-441. PubMed ID: 35857251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells.
    Reikvam H; Nepstad I; Bruserud Ø; Hatfield KJ
    Oncotarget; 2013 Jun; 4(6):830-43. PubMed ID: 23919981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response.
    Yu Z; Chen T; Li X; Yang M; Tang S; Zhu X; Gu Y; Su X; Xia M; Li W; Zhang X; Wang Q; Cao X; Wang J
    Elife; 2016 Apr; 5():. PubMed ID: 27063938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO21 mediates the ubiquitylation and proteasomal degradation of EID1.
    Watanabe K; Yumimoto K; Nakayama KI
    Genes Cells; 2015 Aug; 20(8):667-74. PubMed ID: 26085330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.